DePuy recalls discontinued hip replacement devices

DePuy has voluntarily recalled two of its hip replacement products due to the number of patients implanted with the devices needing revision surgery.

DePuy has voluntarily recalled two of its hip replacement products due to the number of patients implanted with the devices needing revision surgery.

The company recalled its ASR XL acetabular system and the DePuy ASR hip resurfacing system, advising all implanted patients to...

More from Archive

More from Medtech Insight

‘Eyes – A Window Into The Heart’: Retinal AI Tool Predicts Future Risk Of Heart Attack And Stroke

 

A deep-learning AI-based retinal image scanning tool can predict the risk of cardiovascular events over a 10-year period with 70% accuracy. The test is comparable to routine GP health checks, researchers from the University of Dundee have shown.

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep & FDA Rules

In this week's Digital Health Roundup, Medtech Insight's team discusses progress on autonomous surgery, Medtronic's new partnership with IRCAD, FDA cybersecurity news, and C-suite interviews with OpenWater, Flow Neuroscience and EnsoData.

Whoops! FDA Says Company Marketed Unauthorized Device. The Company Says The FDA Is Wrong

 

A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.